(Quote) Joseph-750000 said:
Your last line says it all Paul. "Government just does not belong in health care". The...
(Quote) Joseph-750000 said:
Your last line says it all Paul. "Government just does not belong in health care". The role of government in health care should be limited to regulations which ensure licensing of medical professionals, the safety and purity of pharmaceuticals and cleanliness of clinical environments, insurance regulations that protect patients from discrimination etc.... This is the true role of Congress - to regulate in order to create a safe and fair playing field for free market to florish, but NOT to run the industry themselves!
Medicare is perfect example. The Social Security System would be robust today as a retirement benefit. It is Medicare which threatens to destroy it for reasons such as those you have mentioned. The real problem here is the spiraling COSTS of medical treatment, and Obamacare doesn't fix it, it merely redistributes the costs. The out-of-control costs that are ruining American health care include: Trial lawyers who siphon millions in health care dollars in cases which rarely go to trial, but are settled out of court. The attorney takes a big chunk and moves on to the next client. Does anyone really believe that doctors and malpractice insurers will simply absorb these losses? Of couse not! They find a way to pass it on to the rest of us. Further, as a defensive measure, doctor's burden the system with unneeded tests and procedures just to protect themselves from being sued! We need Tort reform! There is no reason for treatments to be so expensive. These drug companies are gouging consumers to the extreme, and our lawmakers do nothing. We need changes in the competitive structure of the phamaceutical industry! Health care providers for too long have shamelessly discriminated against consumers (though I admit that Obamacare does address this to a degree) and like drug companies, are in need of competitive restructuring as well. Don't believe for a minute that these Obamacare "health care exchanges", which will be created by each state, will solve it. Health insurers are all in bed with state leaders, and will do anything to limit the competition at your expence! We need leaders who are not afraid to challenge these PAC's, and create a fair and affordable free market health care system. Socialized medicine is NOT the answer!
You are absolutely correct about tort reform. Trial lawyers are one of the most powerful lobbies around. And we have to remember that lawyers are the single largest group of legislators at all levels of Government; Federal, State and local. So lawyers get kid glove treatment in law.
But I have to disagree about pharmaceutical companies. Two things drive the cost of medicines.
1) Ridiculous regulation that makes the development and approval of drugs extremely costly and time consuming. By the time a new, effective drug is approved for use in this country, a major portion of the patent life is already over. All those costs have to be recovered rather quickly. And profits are needed to research and process new drugs
2) The US, in effect, subsidizes, medicines for the rest of the world. Every country with socialized medicine controls the price that can be charged for a medicine by a company. The controlled price is not enough to provide the manufacturer a full recovery of its cots plus enough profits to fund research and development and provide a profit for the owners of the pharmaceutical companies.
So the US being virtually the only free market, we Americans have had to carry the burden for all those socialist countries with out pocketbooks. So yes, we Americans pay to much for medicines because socialists refuse to pay their share.
And if one wants to argue that there are pharmaceutical companies overseas developing drugs and that proves my statement false, forgets that those foreign companies sell their drugs here as well and charge us a price large enough to recover their costs, etc..
And as we spiral into socialized medicine, we too will be putting controls on drug costs which will result in the pipeline of new drugs drying up because costs and new development money will dry up.